A recent meta-analysis based on data from five clinical studies concluded that, compared to patients with lower blood NfL levels, patients with higher levels of NfL in blood samples obtained within the first 7 days after the ischemic stroke event had a 1.71-time higher risk of poor functional outcome during follow-up 3–6 months later [29]. This evidence concerns the gene NEFL and ischemic stroke.